|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0027468,
umls-concept:C0205225,
umls-concept:C0205250,
umls-concept:C0205313,
umls-concept:C0238198,
umls-concept:C0243161,
umls-concept:C0376298,
umls-concept:C0392747,
umls-concept:C0392752,
umls-concept:C0684030,
umls-concept:C1273519,
umls-concept:C1274040,
umls-concept:C1515021,
umls-concept:C1527178,
umls-concept:C1554963
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-6-11
|
|
pubmed:abstractText |
By reappraising the National Institutes of Health (NIH) consensus criteria, we worked on establishing a modified scheme to identify highly lethal gastrointestinal stromal tumors (GISTs), which have an imperative demand for sequencing analysis to assess the suitability of an adjuvant imatinib trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0039-6060
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
141
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
748-56
|
|
pubmed:meshHeading |
pubmed-meshheading:17560251-Adult,
pubmed-meshheading:17560251-Aged,
pubmed-meshheading:17560251-Aged, 80 and over,
pubmed-meshheading:17560251-Cohort Studies,
pubmed-meshheading:17560251-Consensus,
pubmed-meshheading:17560251-Female,
pubmed-meshheading:17560251-Follow-Up Studies,
pubmed-meshheading:17560251-Gastrointestinal Stromal Tumors,
pubmed-meshheading:17560251-Humans,
pubmed-meshheading:17560251-Male,
pubmed-meshheading:17560251-Middle Aged,
pubmed-meshheading:17560251-Multivariate Analysis,
pubmed-meshheading:17560251-National Institutes of Health (U.S.),
pubmed-meshheading:17560251-Prognosis,
pubmed-meshheading:17560251-Retrospective Studies,
pubmed-meshheading:17560251-Risk Assessment,
pubmed-meshheading:17560251-Survival Analysis,
pubmed-meshheading:17560251-Treatment Outcome,
pubmed-meshheading:17560251-United States
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome.
|
|
pubmed:affiliation |
Department of Pathology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
